Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The type 1 immune response is a specialized arm of the immune system designed to protect the body against intracellular pathogens, such as viruses and certain bacteria. It involves both innate and adaptive immunity, with a focus on cell-mediated effector mechanisms. It is characterized by the activation of ILC1s, CD8+ cytotoxic T cells, and CD4+ T helper 1 cells, and the production of IFN-γ and other pro-inflammatory cytokines.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type 1 Immune Response (Type 1 Immunity).